Immunova
Clinical-stage oncology company developing nanotechnology-enabled therapeutics designed to engage multiple targets simultaneously and advance candidate medicines into clinical development.
Industries
biotechnology
nanotechnology
oncology
pharmaceutical
Nr. of Employees
small (1-50)
Immunova
New Canaan, Connecticut, United States, North America
Products
Nanomedicines for Cancer Treatment
Immunova develops nanomedicines designed to target multiple cancer-related pathways simultaneously, aiming to improve patient outcomes.
Nanomedicines for Cancer Treatment
Immunova develops nanomedicines designed to target multiple cancer-related pathways simultaneously, aiming to improve patient outcomes.
Expertise Areas
- Oncology drug development
- Clinical development (clinical-stage programs)
- Nanotechnology-enabled therapeutics
- Multi-target therapeutic strategies
Key Technologies
- Nanotechnology
- Multi-target therapeutic design
- Targeted drug delivery